Based on reported financial statement history.
Over the past 12 months, Net Income CAGR is -3.42%.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Net income CAGR shows how the company's bottom-line profitability has grown. This reflects the company's ability to convert revenue into profits after all expenses.
Medline Inc. (MDLN)
Net Income growth vs the same quarter one year earlier, last 3 quarters.
Reported quarterly net income; no daily interpolation.
| Year | Start Net Income | End Net Income | Change | % Change |
|---|---|---|---|---|
| 2025 | $1.20B | $1.16B | −$41.00M | -3.42% |
| 2024 | $234.00M | $1.20B | +$966.00M | +412.82% |
| 2023 | −$25.00M | $234.00M | +$259.00M | N/A |
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Quarter ended Mar 2026 | $129.00M | -28.3% | -59.9% |
| Quarter ended Dec 2025 | $180.00M | -44.1% | -44.4% |
| Quarter ended Sep 2025 | $322.00M | -3.3% | +10.3% |
| Quarter ended Jun 2025 | $333.00M | +3.4% | N/A |
| Quarter ended Mar 2025 | $322.00M | -0.6% | N/A |
| Quarter ended Sep 2024 | $324.00M | +11.0% | N/A |
| Quarter ended Jun 2024 | $292.00M | N/A | N/A |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
